0001209191-20-036824.txt : 20200615 0001209191-20-036824.hdr.sgml : 20200615 20200615201213 ACCESSION NUMBER: 0001209191-20-036824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200612 FILED AS OF DATE: 20200615 DATE AS OF CHANGE: 20200615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hardiman Roy C. CENTRAL INDEX KEY: 0001506218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38653 FILM NUMBER: 20964689 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Principia Biopharma Inc. CENTRAL INDEX KEY: 0001510487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263487603 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 220 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 416-7700 MAIL ADDRESS: STREET 1: 220 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-12 0 0001510487 Principia Biopharma Inc. PRNB 0001506218 Hardiman Roy C. C/O PRINCIPIA BIOPHARMA INC. 220 E. GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Business Officer Common Stock 2020-06-12 4 M 0 5000 4.7236 A 122761 D Common Stock 2020-06-12 4 S 0 1595 59.9003 D 121166 D Common Stock 2020-06-12 4 S 0 2542 61.6169 D 118624 D Common Stock 2020-06-12 4 S 0 863 62.1289 D 117761 D Common Stock 1916 I See footnote Employee Stock Option (right to buy) 4.7236 2020-06-12 4 M 0 5000 0.00 D 2025-02-25 Common Stock 5000 2758 D Includes 858 shares shares acquired under the Employment Stock Purchase Plan on May 15, 2020. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Represents the weighted average sales price per share. The shares sold at prices ranging from $59.41 to $60.23 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Represents the weighted average sales price per share. The shares sold at prices ranging from $61.00 to $61.98 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Represents the weighted average sales price per share. The shares sold at prices ranging from $62.03 to $62.63 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Shares indirectly held by Roy Hardiman, as custodian for his minor child under California Uniform Transfers to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares. The stock option is fully vested and immediately exercisable. /s/ Christopher Y. Chai, Attorney-in-Fact for Roy Hardiman 2020-06-15